These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31861435)

  • 1. Maspin is a PTEN-Upregulated and p53-Upregulated Tumor Suppressor Gene and Acts as an HDAC1 Inhibitor in Human Bladder Cancer.
    Lin YH; Tsui KH; Chang KS; Hou CP; Feng TH; Juang HH
    Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31861435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BTG2 is a tumor suppressor gene upregulated by p53 and PTEN in human bladder carcinoma cells.
    Tsui KH; Chiang KC; Lin YH; Chang KS; Feng TH; Juang HH
    Cancer Med; 2018 Jan; 7(1):184-195. PubMed ID: 29239139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgelin, a p53 and PTEN-Upregulated Gene, Inhibits the Cell Proliferation and Invasion of Human Bladder Carcinoma Cells in Vitro and in Vivo.
    Tsui KH; Lin YH; Chang KS; Hou CP; Chen PJ; Feng TH; Juang HH
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31591355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metallothionein 3 Is a Hypoxia-Upregulated Oncogene Enhancing Cell Invasion and Tumorigenesis in Human Bladder Carcinoma Cells.
    Tsui KH; Hou CP; Chang KS; Lin YH; Feng TH; Chen CC; Shin YS; Juang HH
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth differentiation factor-15: a p53- and demethylation-upregulating gene represses cell proliferation, invasion, and tumorigenesis in bladder carcinoma cells.
    Tsui KH; Hsu SY; Chung LC; Lin YH; Feng TH; Lee TY; Chang PL; Juang HH
    Sci Rep; 2015 Aug; 5():12870. PubMed ID: 26249737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate-derived ets factor represses tumorigenesis and modulates epithelial-to-mesenchymal transition in bladder carcinoma cells.
    Tsui KH; Lin YH; Chung LC; Chuang ST; Feng TH; Chiang KC; Chang PL; Yeh CJ; Juang HH
    Cancer Lett; 2016 May; 375(1):142-151. PubMed ID: 26965996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of Maspin Expression in Bladder Cancer: Its Relationship with p53 and Clinicopathological Parameters.
    Abd El-Maqsoud NM; Tawfiek ER
    J Egypt Natl Canc Inst; 2010 Mar; 22(1):1-12. PubMed ID: 21503001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and regulation of tumor suppressor gene maspin in human bladder cancer.
    Sugimoto S; Maass N; Takimoto Y; Sato K; Minei S; Zhang M; Hoshikawa Y; Jünemann KP; Jonat W; Nagasaki K
    Cancer Lett; 2004 Jan; 203(2):209-15. PubMed ID: 14732229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous inhibition of histone deacetylase 1 by tumor-suppressive maspin.
    Li X; Yin S; Meng Y; Sakr W; Sheng S
    Cancer Res; 2006 Sep; 66(18):9323-9. PubMed ID: 16982778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-inducible protein IFIXalpha inhibits cell invasion by upregulating the metastasis suppressor maspin.
    Yamaguchi H; Ding Y; Lee JF; Zhang M; Pal A; Bornmann W; Yan DH; Hung MC
    Mol Carcinog; 2008 Oct; 47(10):739-43. PubMed ID: 18247378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAp63gamma can substitute for p53 in inducing expression of the maspin tumor suppressor.
    Spiesbach K; Tannapfel A; Mössner J; Engeland K
    Int J Cancer; 2005 Apr; 114(4):555-62. PubMed ID: 15578720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of maspin expression in human cervical carcinoma cells by transforming growth factor β1 through the convergence of Smad and non-Smad signaling pathways.
    Wongnoppavich A; Dukaew N; Choonate S; Chairatvit K
    Oncol Lett; 2017 May; 13(5):3646-3652. PubMed ID: 28521467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression analysis of maspin in invasive ductal carcinoma of breast and modulation of its expression by curcumin in breast cancer cell lines.
    Prasad CP; Rath G; Mathur S; Bhatnagar D; Ralhan R
    Chem Biol Interact; 2010 Feb; 183(3):455-61. PubMed ID: 19944674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTEN and p53 are required for hypoxia induced expression of maspin in glioblastoma cells.
    Eitel JA; Bijangi-Vishehsaraei K; Saadatzadeh MR; Bhavsar JR; Murphy MP; Pollok KE; Mayo LD
    Cell Cycle; 2009 Mar; 8(6):896-901. PubMed ID: 19221500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy.
    Chen J; Wang L; Tang Y; Gong G; Liu L; Chen M; Chen Z; Cui Y; Li C; Cheng X; Qi L; Zu X
    J Exp Clin Cancer Res; 2016 Jan; 35():2. PubMed ID: 26733306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metallothionein 3: an androgen-upregulated gene enhances cell invasion and tumorigenesis of prostate carcinoma cells.
    Juang HH; Chung LC; Sung HC; Feng TH; Lee YH; Chang PL; Tsui KH
    Prostate; 2013 Oct; 73(14):1495-506. PubMed ID: 23794209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of maspin is a helpful prognosticator in colorectal cancer: a tissue microarray analysis.
    Boltze C
    Pathol Res Pract; 2005; 200(11-12):783-90. PubMed ID: 15792121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maspin in thyroid cancer: its relationship with p53 and clinical outcome.
    Boltze C; Schneider-Stock R; Meyer F; Peters B; Quednow C; Hoang-Vu C; Roessner A
    Oncol Rep; 2003; 10(6):1783-7. PubMed ID: 14534696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Maspin in non-muscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis.
    Friedrich MG; Toma MI; Petri S; Cheng JC; Hammerer P; Erbersdobler A; Huland H
    Eur Urol; 2004 Jun; 45(6):737-43. PubMed ID: 15149745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
    Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M
    Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.